Skip to main content
PMC home page
BMC Cancer logoLink to BMC Cancer
. 2019 May 23;19:492. doi: 10.1186/s12885-019-5699-9

Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol

Chen Li 1,#, Xiaomin Wang 2,#, Xin Wang 1,#, Chun Han 3, Ping Wang 4, Qingsong Pang 4, Junqiang Chen 5, Xinchen Sun 6, Lan Wang 3, Wencheng Zhang 4, Yu Lin 5, Xiaolin Ge 6, Zongmei Zhou 1, Wenjie Ni 1, Xiao Chang 1, Jun Liang 7, Lei Deng 1, Wenqing Wang 1, Yidian Zhao 2,✉, Zefen Xiao 1,✉
PMCID: PMC6533695  PMID: 31122185

Correction to: BMC Cancer, 2019; 19:397

https://doi.org/10.1186/s12885-019-5544-1

Following publication of the original article [1], the authors reported that an error in the Methods/Design, Study design and objectives section (third sentence). The dose of “50.4Gy/2.14Gy/28f” is incorrect and should be “50.4Gy/1.80Gy/28f”.

The sentence should read: The technique of SIB is adopted in this study with a dose of 50.4Gy/1.80Gy/28f to planning target volume (PTV) and 59.92Gy/2.14Gy/28f to planning gross tumor volume (PGTV).

The authors apologise for the inconvenience caused.

Contributor Information

Yidian Zhao, Email: ayydz101@163.com.

Zefen Xiao, Email: xiaozefen@sina.com.

Reference

  • 1.Li et al. A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol. BMC Cancer. 2019;19:397. doi: 10.1186/s12885-019-5544-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES